Abbott Can't Ax False Ad Attack In Probiotic IP Row
An Illinois federal judge held Tuesday that the maker of Similac infant formula, Abbott Laboratories, can't boot its rival's false advertising counterclaims in a patent suit over baby probiotics, finding that...To view the full article, register now.
Already a subscriber? Click here to view full article